CA2411153A1 - Method for preparing a composition - Google Patents
Method for preparing a compositionInfo
- Publication number
- CA2411153A1 CA2411153A1 CA002411153A CA2411153A CA2411153A1 CA 2411153 A1 CA2411153 A1 CA 2411153A1 CA 002411153 A CA002411153 A CA 002411153A CA 2411153 A CA2411153 A CA 2411153A CA 2411153 A1 CA2411153 A1 CA 2411153A1
- Authority
- CA
- Canada
- Prior art keywords
- compositions
- preparing
- solution
- homogeneous dispersion
- relates
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000007970 homogeneous dispersion Substances 0.000 abstract 2
- 238000009835 boiling Methods 0.000 abstract 1
- 239000006185 dispersion Substances 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 239000006260 foam Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
The present invention relates to a method for the preparation of compositions, preferably pharmaceutical compositions, in form of expanded, mechanically stable, lamellar, porous, spongue-like or foam structures out of solutions and dispersions. This method comprises the steps of a) preparing a solution or a homogeneous dispersion of a liquid and a compound selected from the group consisting of one or more pharmaceutically active compounds, one or more pharmaceutically suitable excipients, and mixtures thereof, followed by b) the expansion of the solution or the homogeneous dispersion without boiling. The invention also relates to the compositions, their further processing and any corresponding dosage forms obtainable by the above method.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00113535.9 | 2000-06-27 | ||
EP00113535 | 2000-06-27 | ||
PCT/EP2001/006834 WO2002000201A2 (en) | 2000-06-27 | 2001-06-18 | Method for preparing a composition |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2411153A1 true CA2411153A1 (en) | 2002-01-03 |
CA2411153C CA2411153C (en) | 2007-01-30 |
Family
ID=8169074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002411153A Expired - Lifetime CA2411153C (en) | 2000-06-27 | 2001-06-18 | Method for preparing a composition |
Country Status (38)
Country | Link |
---|---|
US (3) | US6534087B2 (en) |
EP (1) | EP1296656B1 (en) |
JP (2) | JP4149803B2 (en) |
KR (1) | KR100557845B1 (en) |
CN (1) | CN1236764C (en) |
AR (1) | AR029278A1 (en) |
AT (1) | ATE334662T1 (en) |
AU (2) | AU2001281846B2 (en) |
BR (1) | BRPI0112014B1 (en) |
CA (1) | CA2411153C (en) |
CY (1) | CY1105714T1 (en) |
CZ (1) | CZ301813B6 (en) |
DE (1) | DE60121953T2 (en) |
DK (1) | DK1296656T3 (en) |
EC (1) | ECSP024401A (en) |
EG (1) | EG24141A (en) |
ES (1) | ES2269441T3 (en) |
HK (1) | HK1058314A1 (en) |
HR (1) | HRP20021009B1 (en) |
HU (1) | HU229550B1 (en) |
IL (2) | IL153282A0 (en) |
JO (1) | JO2247B1 (en) |
MA (1) | MA26922A1 (en) |
ME (1) | ME00672B (en) |
MX (1) | MXPA02012583A (en) |
MY (1) | MY129798A (en) |
NO (1) | NO332181B1 (en) |
NZ (1) | NZ523024A (en) |
PE (1) | PE20020101A1 (en) |
PL (1) | PL203804B1 (en) |
PT (1) | PT1296656E (en) |
RU (1) | RU2244542C2 (en) |
SI (1) | SI1296656T1 (en) |
TW (1) | TWI278325B (en) |
UY (1) | UY26799A1 (en) |
WO (1) | WO2002000201A2 (en) |
YU (1) | YU96602A (en) |
ZA (1) | ZA200209649B (en) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9827423D0 (en) * | 1998-12-11 | 1999-02-03 | Relax Limited | Method of drying a solution |
ES2269441T3 (en) * | 2000-06-27 | 2007-04-01 | F. Hoffmann-La Roche Ag | METHOD FOR THE PREPARATION OF A COMPOSITION. |
US20030027786A1 (en) * | 2001-06-06 | 2003-02-06 | Karsten Maeder | Lipase inhibiting composition |
MY135783A (en) * | 2001-09-07 | 2008-06-30 | Meiji Dairies Corp | Nutritional composition for controlling blood sugar level |
JP4234017B2 (en) * | 2002-04-26 | 2009-03-04 | エフ.ホフマン−ラ ロシュ アーゲー | Pharmaceutical composition comprising a lipase inhibitor and glucomannan |
KR100517072B1 (en) * | 2002-11-25 | 2005-09-26 | 주식회사 태평양 | Polyol/polymer microcapsule and the stabilization method of enzyme using it |
US9174176B2 (en) * | 2003-01-09 | 2015-11-03 | Disperse Systems, Inc. | Ultrasonic dispersion apparatus, system, and method |
WO2005021056A1 (en) * | 2003-08-21 | 2005-03-10 | Cns, Inc. | Effervescent delivery system |
US8940321B2 (en) | 2003-12-12 | 2015-01-27 | Otic Pharma Ltd. | Compositions for treatment of ear disorders and methods of use thereof |
WO2005055921A2 (en) * | 2003-12-12 | 2005-06-23 | Eran Eilat | Compositions for treatment of ear disorders and methods of use thereof |
CA2562213A1 (en) * | 2004-04-06 | 2005-11-24 | Rpg Life Sciences Limited | Mouth dissolvable and meltable, and water dispersable delivery formulation |
JP4329816B2 (en) * | 2004-09-15 | 2009-09-09 | 萬有製薬株式会社 | Sampling method, sampling device, logD measuring method and logD measuring system |
WO2006073333A2 (en) * | 2004-12-31 | 2006-07-13 | Mikhail Yurievich Gotovsky | Magnetoresonance preparations, device for individually selecting said preparations for increasing an organism life activity in actual environmental conditions |
US20060198856A1 (en) * | 2005-03-01 | 2006-09-07 | Keith Whitehead | Ibuprofen suspension stabilized with docusate sodium |
US20060246141A1 (en) * | 2005-04-12 | 2006-11-02 | Elan Pharma International, Limited | Nanoparticulate lipase inhibitor formulations |
US7984717B2 (en) * | 2005-04-29 | 2011-07-26 | Medtronic, Inc. | Devices for augmentation of lumen walls |
US20070060610A1 (en) * | 2005-06-16 | 2007-03-15 | Wempe Michael F | Methods and pharmaceutical formulations for increasing bioavailability |
WO2006136197A1 (en) | 2005-06-21 | 2006-12-28 | V. Mane Fils | Smoking device incorporating a breakable capsule, breakable capsule and process for manufacturing said capsule |
US20070048364A1 (en) * | 2005-08-04 | 2007-03-01 | Yingxu Peng | Free flowing granules containing carbomer |
KR100669497B1 (en) * | 2005-08-17 | 2007-01-16 | 보람제약주식회사 | Pharmaceutical formulation with high stability and dissolution and manufacturing method |
AR056499A1 (en) * | 2005-09-06 | 2007-10-10 | Serapis Farmaceuticals Ltd | COMPOUNDS |
WO2007046102A2 (en) | 2005-10-19 | 2007-04-26 | Menni Menashe Zinger | Methods for the treatment of hyperhidrosis |
ES2470340T3 (en) | 2005-12-28 | 2014-06-23 | Advanced Bionutrition Corporation | Administration vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in vitreous form |
US8968721B2 (en) | 2005-12-28 | 2015-03-03 | Advanced Bionutrition Corporation | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
FR2895908B1 (en) * | 2006-01-12 | 2008-03-28 | France Etat | PROCESS FOR MAKING A PHARMACEUTICAL FORM OF OSELTAMIVIR PHOSPHATE |
CN101389323B (en) | 2006-02-20 | 2013-08-21 | 中外制药株式会社 | Pharmaceutical composition comprising oseltamivir phosphate |
JP2009530614A (en) | 2006-03-16 | 2009-08-27 | デューク ユニバーシティ | Method, system and computer program product for performing real-time quadrature projection based on Fourier domain optical coherence tomography |
CN1820744B (en) * | 2006-04-04 | 2011-01-26 | 中国人民解放军军事医学科学院毒物药物研究所 | Oseltamivir phosphate granula and its preparing method |
EP1872777A1 (en) * | 2006-06-27 | 2008-01-02 | LEK Pharmaceuticals D.D. | Pharmaceutical composition comprising tetrahydrolipstatin |
KR100812824B1 (en) | 2006-09-27 | 2008-03-12 | 주식회사 제닉 | Biocompatible low toxicity film using chitosan and polyethylene glycol |
EP2117354B1 (en) | 2006-12-18 | 2018-08-08 | Advanced BioNutrition Corp. | A dry food product containing live probiotic |
CA2686286A1 (en) * | 2007-05-18 | 2008-11-27 | Tti Ellebeau, Inc. | Transdermal delivery devices assuring an improved release of an active principle through a biological interface |
KR101439470B1 (en) * | 2007-05-22 | 2014-09-16 | 한미사이언스 주식회사 | Composition comprising orlistat and a stool softner for preventing or treating obesity |
US20100317642A1 (en) * | 2007-10-15 | 2010-12-16 | Inventis Dds Pvt Limited | Pharmaceutical composition of orlistat |
PL216542B1 (en) | 2008-03-20 | 2014-04-30 | Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna | Production method of a stable Orlistat composition in form of encapsulated powder |
GB0900551D0 (en) | 2009-01-14 | 2009-02-11 | Horton Richard | Ingestible compositions and processes of preparation |
CA2756883C (en) | 2009-03-27 | 2018-01-09 | Advanced Bionutrition Corp. | Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish |
SG176253A1 (en) | 2009-05-26 | 2011-12-29 | Advanced Bionutrition Corp | Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making |
EP2482802A4 (en) * | 2009-09-29 | 2013-08-07 | Michael Burnet | Novel pesticide formulations |
KR100940745B1 (en) * | 2009-10-15 | 2010-02-04 | 광동제약 주식회사 | Coated pellet containing orlistat and attapulgite and its preparation formulation |
BR112012018839B1 (en) | 2010-01-28 | 2020-04-14 | Advanced Bionutrition Corp | dry glassy composition comprising a bioactive material |
US9504750B2 (en) | 2010-01-28 | 2016-11-29 | Advanced Bionutrition Corporation | Stabilizing composition for biological materials |
KR101021030B1 (en) * | 2010-03-25 | 2011-03-09 | 엘지이노텍 주식회사 | Phosphor coating method, method of fabricating light emitting apparatus, and coated phosphor |
EP2557151B1 (en) * | 2010-04-07 | 2017-10-04 | Mitsubishi Gas Chemical Company, Inc. | S-adenosyl-l-methionine-containing dry yeast composition with excellent storage stability and process for producing same |
ES2676656T3 (en) | 2010-08-13 | 2018-07-23 | Advanced Bionutrition Corp. | Dry storage stabilizer composition for biological materials |
JP2013540827A (en) | 2010-10-29 | 2013-11-07 | ウエスタン ユニバーシティ オブ ヘルス サイエンシズ | Three-mixed preparation |
MX341035B (en) | 2011-03-01 | 2016-08-03 | Procter & Gamble | Porous disintegratable solid substrate for personal health care applications. |
MY178686A (en) | 2012-03-23 | 2020-10-20 | Advanced Bionutrition Corp | Stabilizing composition for biological materials |
CN103222964B (en) * | 2013-01-29 | 2014-10-08 | 青岛大学 | Orlistat oral preparation and preparation method thereof |
GB2524496A (en) * | 2014-03-24 | 2015-09-30 | British Airways Plc | Dynamic tracking and control of passenger travel progress |
US9938558B2 (en) | 2015-06-25 | 2018-04-10 | Ascus Biosciences, Inc. | Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon |
US10851399B2 (en) | 2015-06-25 | 2020-12-01 | Native Microbials, Inc. | Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon |
CN107849597B (en) | 2015-06-25 | 2022-07-26 | 原生微生物股份有限公司 | Method for forming a population of active microbial strains based on analysis of heterogeneous microbial communities |
KR20180080177A (en) | 2015-07-29 | 2018-07-11 | 어드밴스드 바이오뉴트리션 코프. | Stable probiotic dry composition for special dietary uses |
JP6778051B2 (en) * | 2016-08-18 | 2020-10-28 | 沢井製薬株式会社 | Oseltamivir phosphate-containing pharmaceutical composition |
JP2020504620A (en) | 2016-12-28 | 2020-02-13 | アスカス バイオサイエンシーズ, インコーポレイテッド | Methods, apparatus, and systems for analyzing complete microbial strains of complex heterogeneous communities, determining their functional relevance and interaction, and identifying and synthesizing bioreactivity modifiers based thereon |
WO2019069108A1 (en) * | 2017-10-04 | 2019-04-11 | Debreceni Egyetem | Prolonged-release, gastroretentive, moulded, solid dosage form and process for the preparation thereof |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS608117B2 (en) * | 1977-02-08 | 1985-02-28 | 財団法人微生物化学研究会 | New physiologically active substance esterastin and its production method |
US4489438A (en) * | 1982-02-01 | 1984-12-18 | National Data Corporation | Audio response system |
CA1247547A (en) | 1983-06-22 | 1988-12-28 | Paul Hadvary | Leucine derivatives |
ATE216577T1 (en) | 1992-01-29 | 2002-05-15 | Takeda Chemical Industries Ltd | QUICK DISSOLVABLE TABLET AND PRODUCTION THEREOF |
US5560921A (en) | 1992-06-01 | 1996-10-01 | The Procter & Gamble Company | Chewable decongestant compositions |
US5343672A (en) | 1992-12-01 | 1994-09-06 | Scherer Ltd R P | Method for manufacturing freeze dried dosages in a multilaminate blister pack |
CA2151260A1 (en) * | 1993-02-23 | 1994-09-01 | Pankaj B. Gala | A process for the preparation of substantially alcohol free pharmaceutical compositions |
DE4317320A1 (en) | 1993-05-25 | 1994-12-01 | Boehringer Mannheim Gmbh | New thiazolidinediones and medicines containing them |
US5455046A (en) * | 1993-09-09 | 1995-10-03 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems for insoluble drugs |
US5536264A (en) * | 1993-10-22 | 1996-07-16 | The Procter & Gamble Company | Absorbent composites comprising a porous macrostructure of absorbent gelling particles and a substrate |
US5523106A (en) * | 1994-02-03 | 1996-06-04 | Nabisco, Inc. | Juice-based expanded snacks and process for preparing them |
DK0759917T3 (en) | 1995-02-27 | 2000-07-31 | Gilead Sciences Inc | Novel selective inhibitors of viral or bacterial neuraminidases |
NZ520724A (en) | 1995-02-27 | 2004-03-26 | Gilead Sciences Inc | Tetrahydro-pyridine compounds for inhibiting neuraminidase and treating influenza neuraminidase |
CA2223438C (en) * | 1995-06-07 | 2008-05-13 | Quadrant Holdings Cambridge Limited | Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby |
US5763483A (en) * | 1995-12-29 | 1998-06-09 | Gilead Sciences, Inc. | Carbocyclic compounds |
ATE260646T1 (en) * | 1996-04-16 | 2004-03-15 | Novartis Consumer Health Sa | RAPID DISSOLVING ORAL DOSAGE FORM |
US5766520A (en) * | 1996-07-15 | 1998-06-16 | Universal Preservation Technologies, Inc. | Preservation by foam formation |
JP2001505190A (en) * | 1996-10-14 | 2001-04-17 | エフ・ホフマン―ラ ロシュ アーゲー | Preparation method of fine powder preparation |
US6004996A (en) | 1997-02-05 | 1999-12-21 | Hoffman-La Roche Inc. | Tetrahydrolipstatin containing compositions |
US6565885B1 (en) * | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
JPH11137208A (en) | 1997-11-14 | 1999-05-25 | Nikken Chem Co Ltd | Solid material rapidly soluble in oral cavity and its production |
US6267952B1 (en) | 1998-01-09 | 2001-07-31 | Geltex Pharmaceuticals, Inc. | Lipase inhibiting polymers |
JP2002511398A (en) * | 1998-04-09 | 2002-04-16 | エフ.ホフマン−ラ ロシュ アーゲー | Method for producing (sub) micron sized particles by dissolving in compressed gas and surfactant |
BR9912979B1 (en) | 1998-08-14 | 2010-09-21 | orally administrable pharmaceutical composition, chewing tablet, capsule and use of chitosan. | |
DK1105122T3 (en) | 1998-08-14 | 2005-08-08 | Hoffmann La Roche | PHARMACEUTICAL COMPOSITIONS CONTAINING LIPASE INHIBITORS |
GB9827423D0 (en) * | 1998-12-11 | 1999-02-03 | Relax Limited | Method of drying a solution |
US6342249B1 (en) * | 1998-12-23 | 2002-01-29 | Alza Corporation | Controlled release liquid active agent formulation dosage forms |
GB9900416D0 (en) | 1999-01-08 | 1999-02-24 | Alizyme Therapeutics Ltd | Inhibitors |
EP1027886B1 (en) | 1999-02-10 | 2008-07-09 | Pfizer Products Inc. | Pharmaceutical solid dispersions |
GB9904629D0 (en) * | 1999-03-02 | 1999-04-21 | Danbiosyst Uk | Oral drug delivery system |
FR2791569B1 (en) * | 1999-03-31 | 2003-05-09 | Pf Medicament | ISOTROPIC FAST DISSOLVING ISOTROPIC MICROPOROUS COMPOSITION OR STRUCTURE FOR PHARMACEUTICAL, VETERINARY, DIETETIC, FOOD OR COSMETIC USE AND PROCESS FOR OBTAINING THE SAME |
ES2269441T3 (en) * | 2000-06-27 | 2007-04-01 | F. Hoffmann-La Roche Ag | METHOD FOR THE PREPARATION OF A COMPOSITION. |
-
2001
- 2001-06-18 ES ES01960323T patent/ES2269441T3/en not_active Expired - Lifetime
- 2001-06-18 CN CNB018119026A patent/CN1236764C/en not_active Expired - Lifetime
- 2001-06-18 ME MEP-2008-906A patent/ME00672B/en unknown
- 2001-06-18 EP EP01960323A patent/EP1296656B1/en not_active Expired - Lifetime
- 2001-06-18 PT PT01960323T patent/PT1296656E/en unknown
- 2001-06-18 PL PL365803A patent/PL203804B1/en unknown
- 2001-06-18 CZ CZ20030212A patent/CZ301813B6/en not_active IP Right Cessation
- 2001-06-18 RU RU2003100506/15A patent/RU2244542C2/en active
- 2001-06-18 AU AU2001281846A patent/AU2001281846B2/en not_active Expired
- 2001-06-18 NZ NZ523024A patent/NZ523024A/en not_active IP Right Cessation
- 2001-06-18 KR KR1020027017564A patent/KR100557845B1/en active IP Right Grant
- 2001-06-18 JP JP2002504983A patent/JP4149803B2/en not_active Expired - Lifetime
- 2001-06-18 HU HU0302060A patent/HU229550B1/en unknown
- 2001-06-18 BR BRPI0112014A patent/BRPI0112014B1/en not_active IP Right Cessation
- 2001-06-18 AT AT01960323T patent/ATE334662T1/en active
- 2001-06-18 CA CA002411153A patent/CA2411153C/en not_active Expired - Lifetime
- 2001-06-18 DE DE60121953T patent/DE60121953T2/en not_active Expired - Lifetime
- 2001-06-18 MX MXPA02012583A patent/MXPA02012583A/en active IP Right Grant
- 2001-06-18 DK DK01960323T patent/DK1296656T3/en active
- 2001-06-18 AU AU8184601A patent/AU8184601A/en active Pending
- 2001-06-18 YU YU96602A patent/YU96602A/en unknown
- 2001-06-18 WO PCT/EP2001/006834 patent/WO2002000201A2/en active IP Right Grant
- 2001-06-18 SI SI200130626T patent/SI1296656T1/en unknown
- 2001-06-18 IL IL15328201A patent/IL153282A0/en active IP Right Grant
- 2001-06-21 PE PE2001000603A patent/PE20020101A1/en active IP Right Grant
- 2001-06-22 TW TW090115313A patent/TWI278325B/en not_active IP Right Cessation
- 2001-06-24 JO JO200199A patent/JO2247B1/en active
- 2001-06-24 EG EG20010680A patent/EG24141A/en active
- 2001-06-25 MY MYPI20012988A patent/MY129798A/en unknown
- 2001-06-25 AR ARP010103011A patent/AR029278A1/en not_active Application Discontinuation
- 2001-06-25 US US09/891,069 patent/US6534087B2/en not_active Expired - Lifetime
- 2001-06-26 UY UY26799A patent/UY26799A1/en not_active IP Right Cessation
-
2002
- 2002-10-08 US US10/266,363 patent/US7074431B2/en not_active Expired - Lifetime
- 2002-11-27 ZA ZA200209649A patent/ZA200209649B/en unknown
- 2002-12-04 IL IL153282A patent/IL153282A/en unknown
- 2002-12-17 HR HR20021009A patent/HRP20021009B1/en not_active IP Right Cessation
- 2002-12-23 NO NO20026197A patent/NO332181B1/en not_active IP Right Cessation
- 2002-12-23 EC EC2002004401A patent/ECSP024401A/en unknown
- 2002-12-26 MA MA26978A patent/MA26922A1/en unknown
-
2004
- 2004-02-19 HK HK04101186A patent/HK1058314A1/en not_active IP Right Cessation
-
2006
- 2006-02-15 US US11/354,716 patent/US20060134205A1/en not_active Abandoned
- 2006-10-19 CY CY20061101498T patent/CY1105714T1/en unknown
-
2007
- 2007-07-10 JP JP2007180722A patent/JP2007302683A/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2411153A1 (en) | Method for preparing a composition | |
WO2001089479A3 (en) | Sustained release pharmaceutical compositions for parenteral administration of hydrophilic compounds | |
CA2402431A1 (en) | 1,2,3,4-tetrahydroisoquinoline derivatives | |
DK0831770T3 (en) | Continuous fluorochemical microdispersions for delivery of pharmaceutical agents | |
CA2317106A1 (en) | Method and composition of an oral preparation of itraconazole | |
EP1136068A3 (en) | Powder containing physiologically active peptide | |
DK0973506T3 (en) | Process for the preparation of solid pharmaceutical dosage forms | |
CA2361402A1 (en) | Bis-sulfonamides | |
EP0992509A3 (en) | Novel macrolide derivatives | |
CA2063273A1 (en) | Surfactant compositions and methods | |
AU2001239625A1 (en) | Method of preparing solid dispersions | |
WO2001005386A3 (en) | Pharmaceutical composition useful for the treatment of tinnitus and hearing loss | |
WO2003035043A3 (en) | Pharmaceutical formulation comprising more than 15% tamoxifen | |
WO2002038133A3 (en) | Compositions containing hydrolytically unstable compounds | |
CA2373166A1 (en) | Antiulcer agent | |
MX231185B (en) | Process for the preparation of pharmaceutical compositions in the form of rapidly desintegrating tablets, which are substantially free of the pharmacologically active principle from the agent crystalline structure modification during the manufacturin | |
CA2066945A1 (en) | Oral, cutaneous and intravaginal pharmaceutical compositions in the form of foam | |
TH32548B (en) | Composition with micronized nebiVolol | |
CA2535742A1 (en) | Preparation of risperidone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20210618 |